The Greater Boston area, encompassing Cambridge, the Seaport District, and the Route 128 corridor, stands as the world's premier hub for biotechnology and life sciences. In this high-stakes environment, the integrity and speed of Electronic Data Capture (EDC) Systems are not just operational requirements—they are the backbone of clinical breakthroughs. From Kendall Square's research labs to the Longwood Medical Area's world-class hospitals, the demand for precise, FDA-compliant data collection has never been higher.
As Boston transitions into the era of Decentralized Clinical Trials (DCT) and Industry 4.0, the synergy between hardware and software is critical. Local organizations are seeking "Information Gain"—the ability to extract actionable insights from raw data faster than competitors. Our EDC systems are engineered to bridge this gap, providing the ruggedness of industrial hardware with the sophisticated connectivity required for real-time cloud integration.
Optimized for Kendall Square's rigorous R&D environments, supporting cold-chain monitoring and reagent tracking with high-precision NFC and 4G connectivity.
Designed for university-led studies (MIT/Harvard), our PDAs facilitate seamless mobile data entry for large-scale longitudinal health studies.
Ruggedized IP67/IP68 devices for the Boston Seaport's burgeoning logistics and advanced manufacturing sectors, ensuring zero-down-time data capture.
Dongguan Trial Medical Co., Ltd. represents the pinnacle of Chinese high-tech manufacturing. Located in the global electronics capital of Dongguan, we combine the efficiency of China's supply chain with the rigorous quality standards demanded by the Boston medical and industrial markets. Since 2016, we have evolved from a specialized manufacturer to a global leader in remote clinical trial monitoring and digital research technologies.
The global EDC market is shifting from "Active Capture" (manual entry) to "Passive Capture" (IoT-driven). For Boston-based firms, this means integrating wearable health data collection and high-speed visual dispensing into their workflows. Our solutions leverage Octa-core processors and advanced Android 9.0/10/11 environments to support AI-at-the-edge, allowing for real-time OCR and pattern recognition without needing constant cloud latency.
Moving clinical trials from clinics to patients' homes using remote monitoring PDAs.
Bridging the gap between ERP, LIMS, and mobile capture devices via Modbus RTU and TCP protocols.
Real-time temperature and humidity logging for high-value biologics using 4G LTE recorders.
How our EDC systems are currently deployed across Massachusetts:
A: Unlike consumer smartphones, rugged PDAs like the JZIOT V9000P offer IP67 waterproofing, enabling them to be sanitized with medical-grade cleaners without damaging the internal electronics. Additionally, dedicated scan engines are significantly faster and more accurate for medication barcoding than standard camera apps.
A: We provide full DDP (Delivered Duty Paid) shipping options to the Boston area, handling all customs and logistics. Our hardware is pre-certified (FCC, CE, RoHS) to ensure seamless integration into American research frameworks.
A: Yes. Our Android-based devices support standard web-based EDC platforms and can be configured with custom APIs to push data directly into clinical trial management systems (CTMS) via secure 4G/5G or encrypted Wi-Fi.
A: For Boston-based clients, we offer a rapid response model: initial design prototypes within 2-3 weeks and mass production within 6-8 weeks, leveraging our Dongguan-based supply chain agility.
Manufacturing Excellence & Compliance
Trial Medical
